Arnold Financial Planning’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Arnold Financial Planning's XBI Position: Q3 2026 in Review
Arnold Financial Planning held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 2,718 shares worth $429K. The position accounts for 0.29% of the portfolio, ranked #28.
Arnold Financial Planning first reported a position in XBI in Q2 2026 and has held it in 2 quarters since. The position peaked at $430K in Q2 2026. 961 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Arnold Financial Planning held 2,718 shares of State Street SPDR S&P Biotech ETF worth $429K as of Q3 2026.
- Arnold Financial Planning left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.29% of Arnold Financial Planning's portfolio in Q3 2026, its #28 holding.
- Arnold Financial Planning first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and has held it in 2 quarters since.
- Arnold Financial Planning's State Street SPDR S&P Biotech ETF position peaked at $430K in Q2 2026.
- 961 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Arnold Financial Planning's 13F filing for Q3 2026, filed 20 Oct 2026.